Vanda Pharmaceuticals Ownership | Who Owns Vanda Pharmaceuticals?


OverviewForecastRevenueFinancialsChartTranscripts

Vanda Pharmaceuticals Ownership Summary


Vanda Pharmaceuticals is owned by 71.06% institutional investors, 3.16% insiders, and 25.78% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 15.63% of VNDA shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.99% of its assets in Vanda Pharmaceuticals shares.

VNDA Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockVanda Pharmaceuticals71.06%3.16%25.78%
SectorHealthcare Stocks 57.39%9.93%32.68%
IndustryBiotech Stocks 68.48%9.65%21.87%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock funding, inc. /de9.10M15.63%$43.61M
Blackrock8.14M14.09%$45.98M
Renaissance3.85M6.61%$18.46M
Vanguard group3.51M6.02%$16.80M
Dimensional fund advisors lp2.49M4.27%$11.92M
Tang capital management2.35M4.04%$11.27M
Acadian asset management1.90M3.26%$9.10M
Jacobs levy equity management1.49M2.57%$8.40M
Geode capital management1.45M2.49%$6.95M
State street1.21M2.10%$6.84M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Krensavage asset management662.17K1.72%$3.74M
Profit investment management329.82K1.27%$1.58M
Tang capital management2.35M0.75%$11.27M
Monaco asset management sam392.26K0.27%$1.88M
Clearalpha technologies lp60.00K0.20%$287.40K
Stonepine capital management25.00K0.10%$119.75K
Empire financial management company64.00K0.10%$306.56K
Diametric capital, lp23.70K0.08%$113.52K
Gsa capital partners llp138.42K0.05%$663.00K
Jacobs levy equity management1.49M0.03%$8.40M

Top Buyers

HolderShares% AssetsChange
Krensavage asset management662.17K1.72%662.17K
Blackrock funding, inc. /de9.10M0.00%508.60K
Schonfeld strategic advisors270.54K0.01%270.54K
Millennium management668.69K0.00%269.18K
Susquehanna fundamental investments254.84K0.02%254.84K

Top Sellers

HolderShares% AssetsChange
Nantahala capital management---1.59M
Bank of america corp /de/77.42K--1.13M
Morgan stanley497.22K0.00%-1.01M
Assenagon asset management---730.82K
Apg asset management---371.90K

New Positions

HolderShares% AssetsChangeValue
Krensavage asset management662.17K1.72%662.17K$3.74M
Schonfeld strategic advisors270.54K0.01%270.54K$1.30M
Susquehanna fundamental investments254.84K0.02%254.84K$1.22M
Norges bank115.00K0.00%115.00K$550.85K
Empire financial management company64.00K0.10%64.00K$306.56K

Sold Out

HolderChange
National bank of canada /fi/-2.00
Nelson, van denburg & campbell wealth management group-10.00
Gps wealth strategies group-25.00
Assetmark-31.00
Gamma investing-32.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 2024140-11.39%41,400,330-5.62%711.25%71-2.74%39-23.53%
Sep 30, 20241581.94%43,866,8090.75%751.32%73-14.12%5110.87%
Jun 30, 20241534.79%43,538,769-9.37%751.09%8329.69%46-20.69%
Mar 31, 2024146-8.18%48,037,922-4.96%831.08%64-20.99%585.45%
Dec 31, 2023159-13.11%50,545,253-3.66%871.06%81-10.99%55-17.91%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard US Total Market Shares ETF1.74M2.99%-
Vanguard Total Stock Mkt Idx Inv1.74M2.99%-
iShares Russell 2000 ETF1.50M2.57%22.43K
Vanguard Institutional Extnd Mkt Idx Tr898.43K1.54%-
BlackRock Advantage Small Cap Core Instl844.24K1.45%-
International Biotechnology Ord666.46K1.14%-371.56K
Federated Hermes MDT Small Cap Core IS624.55K1.07%-
Federated Hermes MDT SCC Institutional624.55K1.07%-
Fidelity Small Cap Index563.62K0.97%-10.55K
Nuveen Quant Small Cap Equity R6530.50K0.91%166.10K

Recent Insider Transactions


DateNameRoleActivityValue
Mar 06, 2025Polymeropoulos Mihael Hristos President and CEOBuy$25.10K
Mar 06, 2025Polymeropoulos Mihael Hristos President and CEOBuy$25.05K
Mar 05, 2025Polymeropoulos Mihael Hristos President and CEOBuy$25.15K
Mar 05, 2025Polymeropoulos Mihael Hristos President and CEOBuy$25.05K
Mar 03, 2025Polymeropoulos Mihael Hristos President and CEOBuy$47.05K

Insider Transactions Trends


DateBuySell
2025 Q111-
2024 Q4-1
2024 Q3-1
2024 Q2--
2024 Q1-10

VNDA Ownership FAQ


Who Owns Vanda Pharmaceuticals?

Vanda Pharmaceuticals shareholders are primarily institutional investors at 71.06%, followed by 3.16% insiders and 25.78% retail investors. The average institutional ownership in Vanda Pharmaceuticals's industry, Biotech Stocks , is 68.48%, which Vanda Pharmaceuticals exceeds.

Who owns the most shares of Vanda Pharmaceuticals?

Vanda Pharmaceuticals’s largest shareholders are Blackrock funding, inc. /de (9.1M shares, 15.63%), Blackrock (8.14M shares, 14.09%), and Renaissance (3.85M shares, 6.61%). Together, they hold 36.33% of Vanda Pharmaceuticals’s total shares outstanding.

Does Blackrock own Vanda Pharmaceuticals?

Yes, BlackRock owns 14.09% of Vanda Pharmaceuticals, totaling 8.14M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 45.98M$. In the last quarter, BlackRock decreased its holdings by -1.629K shares, a -0.02% change.

Who is Vanda Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Krensavage asset management is Vanda Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 1.72% of its assets in 662.17K Vanda Pharmaceuticals shares, valued at 3.74M$.

Who is the top mutual fund holder of Vanda Pharmaceuticals shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Vanda Pharmaceuticals shares, with 2.99% of its total shares outstanding invested in 1.74M Vanda Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools